Experiment 489472

Worktypes

PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

HALENAQUINOL SULFATE

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
DNA POLYMERASE ALPHA INHIBITION
OrganismXestospongia sapra (PETROSIIDAE)
CitationIKEGAMI,S: KITAGAWA,I: TAKAYAMA,S: MAKIHARA,R: KOBAYASHI,M: MIYASHIRO,S:. (1991). REVERSE TRANSCRIPTASE INHIBITORS CONTAININ HALENAQUINOL SULFATES.. ()
Amount utilized
Compound isolated
Disease10% INHIBITION WAS RESULTED.
Dose amount160.0 MCG
Number3
Qualitative resultWEAK ACTIVITY
Per unitML
Dose expressionCONC USED